Form 4: Concentra Officer Receives 40,000 Share Stock Grant
Insider Transaction Report
Concentra Group Holdings Parent, Inc. reports an equity grant of 40,000 restricted common shares to Executive Vice President Michael D. Rhine.
Summary
- Michael D. Rhine, Executive Vice President, Chief Operating Officer Onsite Health & Telemedicine, was granted 40,000 shares of Concentra Group Holdings Parent, Inc. common stock.
- The transaction occurred on November 4, 2025.
- The restricted stock will vest in equal annual installments over four years.
- Following this transaction, Michael D. Rhine beneficially owns a total of 80,098 shares of common stock.
Sentiment
Score: 6
Explanation: The filing reports a standard executive compensation event, which is generally viewed as a neutral to slightly positive indicator of corporate governance and executive retention strategy.
Positives
- The grant of restricted stock aligns the executive's long-term interests with those of the shareholders.
- Serves as a retention incentive for a key executive within the company.
Future Outlook
The granted restricted stock will vest in equal annual installments over four years, indicating a long-term retention strategy for the executive and aligning future performance incentives.
Industry Context
This transaction represents a routine executive compensation event, common across industries for retaining key talent and aligning management incentives with long-term company performance.
Related Party Transactions
- Grant of restricted stock to Executive Vice President Michael D. Rhine as part of his compensation package, which is a standard related-party transaction for executive remuneration.
Stakeholder Impact
- Shareholders: The grant aligns the executive's financial interests with the long-term performance of the company, potentially benefiting shareholders through sustained leadership and strategic execution.
- Employees: Reflects standard executive compensation practices, which can influence overall compensation philosophy within the company.
Next Steps
- The restricted stock will vest in equal annual installments over the next four years, subject to continued employment.
Key Dates
| Date | Description |
|---|---|
| 11/04/2025 | Date of earliest transaction, representing the grant of restricted stock to Michael D. Rhine. |
| 11/06/2025 | Signature date of the reporting person's attorney-in-fact for the Form 4 filing. |
Recommendation
holdThis Form 4 reports a routine restricted stock grant to a key executive, which is a standard compensation practice. It does not provide new information that would significantly alter the investment thesis for Concentra Group Holdings Parent, Inc., thus a 'hold' recommendation is appropriate based solely on this filing.
Keywords
Concentra Group Holdings Parent Inc, CON, Form 4, Insider Transaction, Stock Grant, Restricted Stock, Michael D. Rhine, Executive Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.